Open
  
      Actively Recruiting
  
  Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
About
Brief Summary
              
A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.
      Primary Purpose
    
          
      Study Type
    
          
      Phase
    
      Eligibility
      Gender
    
      
      Healthy Volunteers
    
      
      Minimum Age
    
      
      Maximum Age
    
      Inclusion Criteria:
- born between 25 0/7 and 29 6/7 weeks of gestation
 - less than 48 hours of age at first lipid dose (The cohort is defined by gestational age rather than birth weight to avoid an over-represented sample of growth-restricted infants in birth weight defined cohorts.)
 
Exclusion Criteria:
- serious congenital anomalies
 - conditions at birth that will require surgery prior to discharge
 - imminent death such that withdrawal of intensive care support is anticipated within the first 72 hours after birth
 
Join this Trial
      Contact our clinical trial navigators for opportunities that may be suitable for you
    
  
      Study Stats
    
          
      Protocol No.
    
      22-001345
      
  
      Category
    
      Pediatric Disorders
      
          Principal Investigator
        
        
          
      Contact
    
      
        Location
      
      - UCLA Santa Monica
 - UCLA Westwood